Solstice Neurosciences is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solstice's first product named MyoblocÂ® (rimabotulinumtoxinB) Injection in the U.S. and NeuroBlocÂ® (Botulinum Toxin Type B) Injectable Solution in select overseas markets, represents the only botulinum toxin type B currently available to physicians and patients worldwide.
Funding Rounds (2) - $93MUpdate
|Oct 15, 2013||usworldmeds.com - US WorldMeds - Press Releases|
|Apr 19, 2010||solsticeneuro.com - Solstice Neurosciences raises 85000000 in venture round|
|Nov 9, 2006||PE HUB - Solstice Nets $85 Million|
701 Gateway Boulevard
South San Francisco, CA 94080